Dr Shefali Khanna Sharma

Dr Shefali Khanna Sharma
Professor at Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh (July 1, 2020 – Present)
Experience
  • I have over two & a half decades of professional experience of practicing clinical Rheumatology in a tertiary care referral hospital. Although we see all sorts of rheumatology patients, but my area of research interest is Scleroderma, CTD ILD and Women Health in Rheumatological Diseases.
  • I have huge experience in teaching and guiding residents both Junior Residents (MD Medicine) and Senior Residents (DM Rheumatology) and many PhD students.
  • I conduct weekly Journal club for last 7 years. I am also the faculty in charge of student welfare in our department. I am in charge for academic activities like the CPC rooster and Staff Clinic rooster as well.
Awards, Honours & Events
  • Bestowed the Permanent Membership of Global Scleroderma Clinical Trial Consortium (SCTC)
  • Chosen as an executive member of the Indian Rheumatology Association 2021-2023. .
  • Fellow of American College of Rheumatology December, 2019 (FACR)
  • Fellow of Indian College of Physicians (FICP), February 2018
  • Young Scientists International fellowship by Indian Council of Medical Research in Sept 2014.
  • Awarded AbbVie Best Paper Award at APLAR 2015 Chennai for the paper “Effects of Sulfasalazine in axial ankylosing spondylosis a double-blind placebo-controlled trial”.
  • Member of National Academy of Medical Sciences (N. A. M. S.), Oct 2013.
  • Indian Rheumatology Association (IRA) Research Grant-2013 [Assessment of hand arthritis in systemic sclerosis]
  • Coveted Japanese College of Rheumatology (JCR) International Scholarship-2011
  • Prestigious ARA-APLAR (Australian Rheumatology Association -APLAR) International Fellowship.
  • Member of Expert Group of the Association of Physicians of India (API)to formulate the guidelines of adult immunization in 2009. [Recommendations published vide JAPI, April 2009; Vol. 57: 345-356]
Chief Guide in Thesis for MD (Medicine) at PGIMER, Chandigarh.
  • A Randomized control trial to compare the efficacy of oral tacrolimus with oral mycophenolate mofetil in patients of systemic sclerosis interstitial lung disease.
  • To evaluate the presence of coronary artery disease in lupus myocarditis patients and possible association with traditional CAD risk factors as well as SLE related risk factors.
  • Comparison of ovarian function in childhood versus adult onset SLE following treatment with cyclophosphamide.
  • To determine the incidence of abnormal cervical cytology in women with autoimmune disorder who have received intravenous cyclophosphamide.
  • Rheumatic manifestations and quality of life in patients with Chikungunya fever.
  • Comparison of ovarian function in childhood versus adult onset SLE following treatment with cyclophosphamide.
  • Systemic sclerosis causes clinically apparent hand arthritis which is associated with radiographic changes on high resolution US and MRI.
  • Renal manifestations of systemic sclerosis –study of patients in a tertiary hospital in Northern India.
  • Comparison of ovarian reserve in women with SLE following treatment with intravenous cyclophosphamide against those who have received oral mycophenolate mofetil.
  • Assessment of prevalence of tuberculin positivity in early rheumatoid arthritis patients.
Chief Guide In Thesis For DM (Rheumatology):
  • A randomized controlled trial to compare with the efficacy of oral mycophenolate mofetil with
    placebo in patients with systemic sclerosis related early interstitial lung disease.
  • A randomized controlled trial to compare single therapy versus dual therapy in Systemic sclerosis
    related pulmonary arterial hypertension.
  • A randomized controlled trial to compare the efficacy of pirfenidone with placebo for systemic
    sclerosis related interstitial lung disease.
  • Evaluation of Faecal Calprotectin as a marker of disease activity in patients of patients of
    spondylo-arthropathy Before and after treatment with sulfasalazine.
  • [68Ga]- CPCR4 trifluoroacetate PET/CT imaging of chemokine receptor CXCR4- expression in
    Systemic Sclerosis related Interstitial Lung Disease